ABSTRACT
Peptidoglycan is an essential component of the bacterial cell envelope that sustains the turgor pressure of the cytoplasm, determines cell shape, and acts as a scaffold for the anchoring of envelope polymers such as lipoproteins. The final cross-linking step of peptidoglycan polymerization is performed by classical d,d-transpeptidases belonging to the penicillin-binding protein (PBP) family and by l,d-transpeptidases (LDTs), which are dispensable for growth in most bacterial species and whose physiological functions remain elusive. In this study, we investigated the contribution of LDTs to cell envelope synthesis in Pseudomonas aeruginosa grown in planktonic and biofilm conditions. We first assigned a function to each of the three P. aeruginosa LDTs by gene inactivation in P. aeruginosa, heterospecific gene expression in Escherichia coli, and, for one of them, direct determination of its enzymatic activity. We found that the three P. aeruginosa LDTs catalyze peptidoglycan cross-linking (LdtPae1), the anchoring of lipoprotein OprI to the peptidoglycan (LdtPae2), and the hydrolysis of the resulting peptidoglycan-OprI amide bond (LdtPae3). Construction of a phylogram revealed that LDTs performing each of these three functions in various species cannot be assigned to distinct evolutionary lineages, in contrast to what has been observed with PBPs. We showed that biofilm, but not planktonic bacteria, displayed an increase proportion of peptidoglycan cross-links formed by LdtPae1 and a greater extent of OprI anchoring to peptidoglycan, which is controlled by LdtPae2 and LdtPae3. Consistently, deletion of each of the ldt genes impaired biofilm formation and potentiated the bactericidal activity of EDTA. These results indicate that LDTs contribute to the stabilization of the bacterial cell envelope and to the adaptation of peptidoglycan metabolism to growth in biofilm.
IMPORTANCE Active-site cysteine LDTs form a functionally heterologous family of enzymes that contribute to the biogenesis of the bacterial cell envelope through formation of peptidoglycan cross-links and through the dynamic anchoring of lipoproteins to peptidoglycan. Here, we report the role of three P. aeruginosa LDTs that had not been previously characterized. We show that these enzymes contribute to resistance to the bactericidal activity of EDTA and to the adaptation of cell envelope polymers to conditions that prevail in biofilms. These results indicate that LDTs should be considered putative targets in the development of drug-EDTA associations for the control of biofilm-related infections.
KEYWORDS: l,d-transpeptidases; biofilms; lipoproteins; peptidoglycan
INTRODUCTION
Peptidoglycan is a major component of the cell envelope that is present in almost all bacterial species. This complex heteropolymer is composed of linear glycan chains cross-linked by short stem peptides to form a three-dimensional network that surrounds the cytoplasmic membrane and provides resistance to the turgor pressure of the cytoplasm (1). The glycan chains are formed by alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) residues linked together by β-1,4 glycosidic bonds. In Gram-negative bacteria, the d-lactoyl group of MurNAc residues are linked to a conserved peptide stem containing an l-alanine at the first position (l-Ala1), a d-glutamic acid at the second position (d-Glu2), a diaminopimelic acid at the third position (DAP3), and two d-alanines at the fourth and fifth positions (d-Ala4 and d-Ala5). In Gram-positive bacteria, DAP3 is often amidated or replaced by an l-lysine (l-Lys3), which can be substituted by a short side chain (e.g., a pentaglycine in Staphylococcus aureus).
The peptide stems of two adjacent subunits are linked together by peptide cross-links formed by transpeptidases. Most cross-links connect d-Ala4 in an acyl donor stem peptide to DAP3 in an acyl acceptor stem peptide. Synthesis of these so-called 4→3 cross-links is catalyzed by the d,d-transpeptidase activity of penicillin-binding proteins (PBPs) in two steps (2). First, the catalytic serine of PBPs attacks the carbonyl of d-Ala4 in a donor stem pentapeptide, resulting in the formation of an acyl-enzyme and release of d-Ala5. Second, the ester bond of the acyl-enzyme is attacked by the side chain amine of the residue at the 3rd position of an acceptor stem peptide, resulting in the formation of a 4→3 cross-linked peptidoglycan dimer and the release of the PBP (2).
In certain bacteria, peptidoglycan cross-linking is additionally performed by a second family of enzymes, the l,d-transpeptidases (LDTs), which connect residues at the 3rd position of the donor and acceptor stems (3→3 cross-links) (Fig. 1, reaction A) (3, 4). Similar to PBPs, LDTs catalyze peptidoglycan cross-linking by a two-step mechanism involving formation of an acyl-enzyme. However, the acyl donor used by LDTs harbors a tetrapeptide stem instead of a pentapeptide stem. The tetrapeptide-containing substrate of LDTs is formed by hydrolysis of the d-Ala4–d-Ala5 amide bond of pentapeptide stems by d,d-carboxypeptidases (5–7). LDTs and PBPs also differ by the catalytic nucleophile, Cys versus Ser, and the two enzyme families are structurally unrelated (8). PBPs and LDTs are inactivated through acylation of their nucleophiles. PBPs are potentially inactivated by all classes of β-lactams. In contrast, LDTs are effectively inactivated only by β-lactams belonging to the carbapenem class (9–13).
FIG 1.
Two-step reactions catalyzed by LDTs. In the first step, the catalytic cysteine attacks the carbonyl of d-Ala4 at the extremity of an acyl donor tetrapeptide stem. This results in the formation of an acyl-enzyme and the release of d-Ala4. In the second step, the carbonyl of the thioester bond in the acyl-enzyme is attacked by a side chain amine harbored either by DAP3 in an acceptor stem peptide (reaction A, formation of 3→3 cross-links) or by the C-terminal l-Lys of Lpp (reaction B, Lpp anchoring). Other members of the LDT family hydrolyze the tripeptide→Lpp amide bond (reaction C, release of Lpp). Abbreviations: DAP, diaminopimelic acid; d-iGlu, d-isoglutamic acid; Lpp, major outer membrane Braun lipoprotein; FA, fatty acid.
Since the first characterization of an LDT in a highly ampicillin-resistant mutant of Enterococcus faecium selected in vitro (4), numerous members of the LDT family have been identified in Gram-positive and Gram-negative bacteria as well as in mycobacteria (14–17). The number of LDTs differs between bacterial species, ranging from 1 in Neisseria meningitidis and Helicobacter pylori to 21 in Bradyrhizobium japonicum (18). A wide variety of functions that can be classified in three groups has been associated with these enzymes, as follows.
A first group of LDTs forms 3→3 peptidoglycan cross-links and comprises enzymes with various physiological functions (Fig. 1, reaction A). Certain LDTs participate in the maturation of peptidoglycan in Mycobacterium smegmatis (19, 20) and in β-lactam resistance in mutants of Escherichia coli and E. faecium selected in vitro (4, 7). In these E. coli and E. faecium mutants, the LDTs can fully replace the PBPs, resulting in a peptidoglycan exclusively containing 3→3 cross-links. The proportion of 3→3 cross-links formed by LDTs is highly variable in wild-type bacteria, ranging from 70% to 80% in Clostridioides difficile (14) and mycobacteria (21, 22) to <10% in most species, including in E. coli (23). LDTs are essential for virulence in Mycobacterium tuberculosis (24) but fully dispensable in E. coli, at least for growth in laboratory conditions. In the latter bacterium, the proportion of 3→3 cross-links increases in the stationary phase of growth, but this observation has not been associated with any phenotypic property (25). In E. coli, 3→3 cross-link formation was reported to participate in peptidoglycan remodeling, thereby increasing the overall robustness of the bacterial cell envelope in response to defects in the outer membrane (26). In Salmonella enterica serovar Typhi, an l,d-transpeptidase plays an essential role in typhoid toxin secretion (27). The enzyme edits the peptidoglycan, i.e., enriches peptidoglycan at the cell poles in 3→3 cross-links, thereby enabling specific cleavage of these cross-links by a specialized muramidase for translocation of the toxin though the peptidoglycan layer. This subsequently enables the release of the toxin through the outer membrane.
A second group of LDTs is specialized in the covalent anchoring of proteins to peptidoglycan (Fig. 1, reaction B). In E. coli, three LDTs anchor the Braun lipoprotein (Lpp), providing a link between the peptidoglycan and the outer membrane that is thought to contribute to the stability of the envelope (28–30). In Coxiella burnetii, the cell envelope has been proposed to be similarly stabilized by the anchoring of an outer membrane barrel protein to peptidoglycan by an LDT during the stationary phase of growth (31).
A third group of LDTs comprises enzymes acting as hydrolases (Fig. 1, reaction C). In E. coli, a member of the LDT family, YafK (also known as DpaA), was found to exclusively display hydrolytic activity for cleavage of the amide bond connecting Lpp to tripeptide stems (32, 33). In combination with LDTs that anchor Lpp, this enzyme may dynamically control the equilibrium between the free and peptidoglycan-linked forms of Lpp.
In addition to the three types of amide bond-forming and -hydrolyzing activities depicted as reactions A, B, and C in Fig. 1, LDTs catalyze the exchange of the terminal d-Ala4 of tetrapeptide stems by glycine and various d-amino (e.g., d-Met) and d-2-hyroxy (e.g., d-lactate) acids (3). For the latter reactions, the acyl-enzyme is attacked by the amine or hydroxyl group of free amino or 2-hydroxy acids. This exchange reaction results in the incorporation of d-amino acids in the peptidoglycan, leading to toxic effects. In Vibrio cholerae, noncanonical d-amino acids promote remodeling of peptidoglycan in stationary phase and participate in the control of peptidoglycan abundance and strength (34).
Attack of the acyl-enzyme by a water molecule results in the hydrolysis of the DAP3–d-Ala4 amide bond. In Acinetobacter baumannii, a hydrolytic member of the LDT family acts as an l,d-carboxypeptidase, trimming off d-Ala4 of tetrapeptide stems and thereby contributing to peptidoglycan recycling (35).
Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen, responsible for both acute respiratory infections, in particular ventilator-associated pneumonia, and chronic lung infections in patients with cystic fibrosis and chronic obstructive pulmonary disease. The ability of P. aeruginosa to form biofilms is critical in the pathophysiology of these infections (36–38).
In this study, we show that the chromosome of P. aeruginosa harbors three genes encoding members of the LDT family. We report a functional characterization of each of these three enzymes and the consequences of ldt gene deletions on antibiotic susceptibility, envelope stability, and in vitro formation of biofilms by P. aeruginosa.
RESULTS
The peptidoglycan of P. aeruginosa and E. coli have similar structures.
Our first objective was to determine the structure of peptidoglycan isolated from a stationary-phase culture of P. aeruginosa strain PA14. Peptidoglycan was extracted and digested with muramidases, and the resulting muropeptides were separated by reverse-phase high-performance liquid chromatography (rpHPLC) (Fig. 2A). Mass spectrometry (MS) analysis (Fig. 2B; see Table S1 in the supplemental material) was performed on the material that was collected in each of the individually collected peaks (Fig. 2, peaks 1 to 7). The most abundant stem peptide was a tetrapeptide (l-Ala–d-iGlu–DAP–d-Ala [where iGlu is isoglutamic acid]), both in monomers and in the acceptor stem of dimers. The pentapeptide stem (l-Ala–d-iGlu–DAP–d-Ala–d-Ala) was not detected, indicating that the terminal d-alanines of stem pentapeptides that did not participate in peptidoglycan cross-linking were effectively trimmed off by d,d-carboxypeptidases. Cleavage of DAP–d-Ala amide bonds by l,d-carboxypeptidases or by endopeptidases generated the tripeptide stem l-Ala–d-iGlu–DAP. Most of the dimers (87%) contained 4→3 cross-links made by the d,d-transpeptidase activity of PBPs. The remaining dimers (13%) contained 3→3 cross-links formed by l,d-transpeptidases. Detection of the tripeptide l-Ala–d-iGlu–DAP linked to a Lys-Arg dipeptide (Tri→KR) revealed the anchoring of the OprI lipoprotein to the peptidoglycan (Fig. 1, reaction B). OprI is a homolog (24.8% identity) of the Lpp Braun lipoprotein of E. coli (Fig. S1). The disaccharide moiety was composed exclusively of GlcNAc and reduced MurNAc. Deacylated sugars, as previously reported (39, 40), were not detected, indicating that the corresponding muropeptides were present in insufficient amounts to be identified in our study design. Together, these results showed that all muropeptides detected in E. coli (23) are present in P. aeruginosa PA14. Conversely, no additional structure was detected in P. aeruginosa. Quantitatively, the muropeptide compositions were also very similar, indicating that the peptidoglycan structure is conserved in P. aeruginosa and E. coli.
FIG 2.
Muropeptide composition of the peptidoglycan of P. aeruginosa strain PA14. (A) rpHPLC profile of muropeptides. (B) Structure of muropeptides. Mobs, observed monoisotopic mass; Mcal, calculated monoisotopic mass; gray hexagons, GlcNAc; blue hexagons, MurNAc; black circles, l-Ala; gray circles, d-iGlu; white circles, DAP; green circles, d-Ala; K and R circled in red, amino acid residues corresponding to the Arg-Lys C-terminal extremity of OprI.
Heterospecific expression of P. aeruginosa ldt genes in E. coli reveals the function of the corresponding LDTs.
Our next objective was to identify the LDTs catalyzing the formation of 3→3 cross-linked muropeptides 4 and 6 (Fig. 2) and the anchoring of OprI to the peptidoglycan (Fig. 1, reactions A and B, respectively). Amino acid sequence comparisons using BLASTP as the software and LDTs from E. coli as the queries identified three proteins comprising an YkuD l,d-transpeptidase domain (protein family domain PF03734) with a conserved (S/T)XGCh(R/N) catalytic domain, in which C is the Cys nucleophile, X is any residue, and h is a hydrophobic residue (Fig. S2). The function of these enzymes, designated LdtPae1 (PA14_54810), LdtPae2 (PA14_27180), and LdtPae3 (PA14_15840), was investigated by expressing the corresponding genes in a derivative of E. coli BW25113 obtained by deletion of the complete set of the six E. coli ldt genes (26), here designated E. coli Δ6ldt. The structure of peptidoglycan from this strain and derivatives independently producing each of the three LDTs from P. aeruginosa was determined based on purification of muropeptides by rpHPLC and determination of their structure by MS.
The peptidoglycan of E. coli Δ6ldt used for heterospecific ldt gene expression contained two main muropeptides, a tetrapeptide monomer and a 4→3 cross-linked Tetra→Tetra dimer formed by PBPs. Expression of P. aeruginosa ldtPae1 led to the formation of two additional 3→3 cross-linked dimers containing a tripeptide donor stem and a tripeptide or a tetrapeptide acceptor stem (Tri→Tri and Tri→Tetra dimers) (Fig. 2B, muropeptides 4 and 6; Table 1). These results indicate that LdtPae1 is functional in E. coli and acts as a peptidoglycan cross-linking enzyme in this host.
TABLE 1.
Muropeptide composition of peptidoglycan extracted from derivatives of E. coli Δ6ldt expressing P. aeruginosa l,d-transpeptidase genes
| Muropeptide (cross-link) | Calculated massa | Observed massa of muropeptides for strains with indicated deletion |
|||
|---|---|---|---|---|---|
| None | ldt Pae1 | ldt Pae2 | ldt Pae3 | ||
| Monomers | |||||
| Tri | 870.371 | 870.372 | 870.371 | 870.370 | 870.371 |
| Tetra | 941.408 | 941.408 | 941.409 | 941.408 | 941.409 |
| Tri→KR | 1,154.567 | ND | ND | 1,154.567 | ND |
| Dimers | |||||
| Tri→Tri (3→3) | 1,722.731 | ND | 1,722.730 | ND | ND |
| Tetra→Tri (4→3) | 1,793.768 | ND | 1,793.765 | 1,793.765 | ND |
| Tri→Tetra (3→3) | 1,793.768 | ND | 1,793.765 | ND | ND |
| Tetra→Tetra (4→3) | 1,864.805 | 1,864.805 | 1,864.800 | 1,864.803 | 1,864.800 |
Monoisotopic mass. ND, not detected. Data are representative of three biological repeats.
Heterospecific expression of genes encoding LdtPae2 in E. coli Δ6ldt led to the formation of an additional disaccharide-tripeptide monomer substituted by the dipeptide Lys-Arg (KR) (Fig. 2B, muropeptide 3; Table 1). This observation indicates that LdtPae2 catalyzes the anchoring of Lpp despite the sequence divergence between the sequence of the E. coli (Lpp) and P. aeruginosa (OprI) lipoproteins (24.8% identity) (Fig. S1).
Heterospecific production of LdtPae3 in E. coli Δ6ldt did not lead to any modification of the muropeptide profile. Thus, LdtPae3 did not catalyze formation of 3→3 cross-links or the anchoring of the Braun lipoprotein in E. coli.
Deletion of P. aeruginosa ldt genes confirms the function of LdtPae1, LdtPae2, and LdtPae3 inferred from heterospecific gene expression.
rpHPLC chromatography and MS analyses revealed that deletion of ldtPae1 abolished the formation of 3→3 cross-linked dimers, indicating that LdtPae1 is the only peptidoglycan cross-linking l,d-transpeptidase produced by P. aeruginosa PA14 (Table 2). Deletion of ldtPae2 alone abolished OprI anchoring, indicating that LdtPae2 is the only enzyme responsible for the anchoring of that lipoprotein. Unlike with the parental strain, deletion of ldtPae3 did not result in any modification of the muropeptides. Deletion of the three ldt genes abolished both the formation of 3→3 cross-links and the anchoring of the Lpp lipoprotein. Deletion of the oprI gene prevented formation of muropeptide 3 (Tri→KR; calculated monoisotopic mass [Mcal] = 1,154.567), confirming that this muropeptide originates exclusively from the anchoring of OprI to peptidoglycan. Together, these results (Table 2) indicate that formation of 3→3 cross-linked dimers and lipoprotein anchoring are mediated by LdtPae1 and LdtPae2, respectively, whereas LdtPae3 catalyzes neither reaction, in agreement with the analysis of heterospecific expression of P. aeruginosa ldt genes in E. coli Δ6ldt (see above) (Table 1).
TABLE 2.
Muropeptide composition of the peptidoglycan of derivatives of strain PA14 harboring various deletions
| Muropeptide (cross-link) | Calculated massa | Observed massa of muropeptides for strains with indicated deletion(s) |
|||||
|---|---|---|---|---|---|---|---|
| None | ΔldtPae1 | ΔldtPae2 | ΔldtPae3 | ΔldtPae1 ΔldtPae2 ΔldtPae3 | ΔoprI | ||
| Monomers | |||||||
| Tri | 870.371 | 870.370 | 870.369 | 870.371 | 870.370 | 870.374 | 870.364 |
| Tetra | 941.408 | 941.407 | 941.406 | 941.406 | 941.408 | 941.412 | 941.405 |
| Tri→KR | 1,154.567 | 1,154.566 | 1,154.565 | ND | 1,154.565 | ND | ND |
| Dimers | |||||||
| Tri-Tri (3→3) | 1,722.731 | 1,722.731 | ND | ND | ND | ND | ND |
| Tetra-Tri (4→3) | 1,793.768 | 1,793.766 | 1,793.764 | ND | 1,793.767 | ND | 1,793.761 |
| Tri-Tetra (3→3) | 1,793.768 | 1,793.764 | ND | 1,793.764 | 1,793.766 | ND | 1,793.763 |
| Tetra-Tetra (4→3) | 1,864.805 | 1,864.802 | 1,864.801 | 1,864.799 | 1,864.804 | 1,864.818 | 1,864.800 |
Monoisotopic mass. ND, not detected. Data are representative of three biological repeats except for strain ΔoprI (two repeats).
Purified LdtPae1 catalyzes the formation of 3→3 cross-linked dimers.
In order to validate the catalytic activity of LdtPae1, we produced a soluble fragment of LdtPae1 lacking the membrane anchor (residues 1 to 32) in E. coli and purified by metal affinity and size exclusion chromatography. Consistent with our previous results, LdtPae1 was functional in the formation of 3→3 cross-linked dimers (Fig. 3) using tetrapeptide-containing peptidoglycan fragments as the substrates (Fig. 2B, muropeptide 2). The purified protein also catalyzed the exchanges of d-Ala4 of these substrates by d-Met (Fig. 3). LdtPae1 formed covalent links with β-lactams representative of the cephem (ceftriaxone) and carbapenem (meropenem) classes but not with the penam ampicillin. This β-lactam specificity was previously observed for LDTs from various bacteria (9–13, 41). We could not similarly investigate the catalytic activity of LdtPae2 and LdtPae3, since expression of fragments of the ldtPae2 and ldtPae3 genes under the conditions reported for ldtPae1 did not afford soluble proteins.
FIG 3.
Functional characterization of purified LdtPae1. (A) Schematic representation of the reactions catalyzed by LdtPae1. This enzyme forms an acyl-enzyme with a tetrapeptide donor stem that subsequently reacts with a tetrapeptide acyl acceptor or d-Met, resulting in the formation of a 3→3 cross-linked dimer or of a tetrapeptide ending in d-Met, respectively. LdtPae1 also uses β-lactams as suicide substrates to form acyl-enzymes. (B) Identification of the reaction products by low-resolution MS. The indicated masses are monoisotopic masses for peptidoglycan fragments and average masses for acyl-enzymes. Tetra, reduced disaccharide-tetrapeptide; Lactoyl-Tetra, tetrapeptide linked to the d-lactoyl moiety of MurNAc following cleavage of the ether bond internal to MurNAc; d-Met, d-methionine; None, no reaction product obtained by incubation of purified LdtPae1 with ampicillin. The calculated mass of the native protein is 36,303 Da, corresponding to residues 32 to 347 fused to the MGSSHHHHHHSSG His tag. The N-terminal methionine was not present in purified LdtPae1.
LdtPae1 is unable to bypass β-lactam-inactivated PBPs.
We have previously shown that the d,d-transpeptidase activity of all PBPs can be replaced by the l,d-transpeptidase activity of one of the six LDTs of E. coli, namely, YcbB (7). This results in broad-spectrum β-lactam resistance, because YcbB is not effectively inactivated by β-lactams belonging to the penicillin and cephalosporin classes. In the presence of these drugs, all (>95%) of the peptidoglycan cross-links are of the 3→3 type, indicating that the PBPs do not contribute to peptidoglycan polymerization under such conditions. The bypass resistance mechanism also requires overproduction of the (p)ppGpp alarmone to prevent the bacterial killing triggered by inactivation of the transpeptidase domains of the PBPs (7, 42). This bactericidal activity of β-lactams is thought to result from the uncoupling of the transglycosylation and transpeptidation reactions, thereby leading to the accumulation of un-cross-linked glycan chains in the periplasm and the activation of a futile cycle of glycan chain polymerization and hydrolysis (42). Experimentally, overproduction of (p)ppGpp is achieved in an E. coli BW25113 derivative by the introduction of plasmid pKT8(relA′) encoding an unregulated (p)ppGpp synthase (RelA′) and by the deletion of the chromosomally located relA gene encoding the wild-type (p)ppGpp synthase (7). Although l,d-transpeptidase YnhG from E. coli also catalyzes formation of 3→3 cross-links, this enzyme is unable to confer β-lactam resistance in the host overproducing (p)ppGpp (7). We therefore investigated whether LdtPae1, which forms 3→3 cross-links, was able to bypass PBPs and confer β-lactam resistance in E. coli. To address this question, we introduced plasmid pIHB1, which carries a copy of the ldtPae1 gene under the control of an isopropyl-β-d-thiogalactopyranoside (IPTG)-inducible promoter, in the derivative of E. coli BW25113 that overproduces the (p)ppGpp alarmone. Plasmids coding for inducible production of YcbB and YnhG were used as positive and negative controls, respectively. Production of P. aeruginosa LdtPae1 did not mediate β-lactam resistance in this host, as previously found for E. coli YnhG (Table 3). Thus, YnhG and LdtPae1 were unable to cross-link a functional peptidoglycan under conditions in which the d,d-transpeptidase activity of PBPs was inactivated by β-lactams, even though both proteins are functional LDTs for synthesis of 3→3 peptidoglycan cross-links in vitro and in E. coli. Similar to PBPs involved in peptidoglycan cross-linking, YcbB is a high-molecular-weight protein composed of 615 residues that contains several domains not present in other LDTs, including LDTPae1 and YnhG (Fig. S4). These domains are likely to be essential for the bypass of PBPs by enabling YcbB to recruit accessory proteins required to carry out peptidoglycan cross-linking during the entire cell cycle. These accessory proteins may include the bifunctional transpeptidase-glycosyltransferase class A PBP1b, which displays affinity for YcbB (26), and scaffolding proteins controlling the sites of peptidoglycan expansion during the cell cycle (7, 42).
TABLE 3.
Expression of l,d-transpeptidase-mediated resistance in (p)ppGpp-producing E. colia
| Plasmid | Inhibition zone size (mm) around disks containing indicated β-lactam |
|
|---|---|---|
| Ceftriaxone (30 μg) | Ampicillin (10 μg) | |
| pHV6 (vector) | 37 | 23 |
| pHV6 (ycbB) | 12 | ≤6 |
| pHV6 (ynhG) | 38 | 21 |
| pHV6 (ldtPae1) | 39 | 20 |
The E. coli host harbored a chromosomal deletion of relA and plasmid pKT8 encoding RelA′. Data are median values of three biological repeats.
The activity of β-lactams is not affected by deletion of ldt genes.
The activity of 31 antibiotics, including 20 β-lactams, was tested by the disk diffusion assay against P. aeruginosa PA14 and isogenic derivatives obtained by deletion of l,d-transpeptidase genes (Table S3). Deletion of ldtPae1, ldtPae2 plus ldtPae3, or of the three l,d-transpeptidase genes did not affect the susceptibility of P. aeruginosa to any of the tested antibiotics. Thus, the l,d-transpeptidases did not contribute to growth of PA14 in the presence of subinhibitory concentrations of β-lactams or to the efficacy of the permeability barrier mediated by the outer membrane.
Deletion of ldtPae2 destabilizes the P. aeruginosa envelope.
EDTA is often used to probe the stability of the outer membrane of E. coli, since this compound prevents the stabilization of the outer leaflet of the outer membrane by Mg2+ cations (30, 42). Incubation of P. aeruginosa PA14 derivatives lacking oprI or ldtPae2 resulted in similar kinetics of bacterial killing by EDTA with ~6-log10 decreases of the initial inoculum (Fig. 4). Deletion of ldtPae1 or of ldtPae3 had no impact on killing in comparison to that of wild-type PA14, with <2-log10 decreases of the initial inoculum. Thus, loss of OprI or of the anchoring of this lipoprotein to the peptidoglycan destabilizes the cell envelope, leading to cell death in the presence of EDTA.
FIG 4.
Killing of P. aeruginosa by EDTA. Bacteria from overnight cultures were resuspended in Tris-HCl, pH 8.0, and incubated with 500 μM EDTA (open blue symbols and solid lines) or without EDTA (filled black symbols and dotted lines). Bacteria were enumerated at 0, 90, 180, and 270 min. The numbers of CFU were normalized to the starting inoculum. Data are the mean ± standard error of the mean from three independent biological repeats. * and **, P < 0.05 and P < 0.01, respectively (Brown-Forsythe and Welch ANOVA [wild-type with EDTA versus mutants with EDTA at 270 min]).
Deletion of ldt genes impairs biofilm formation but does not affect motility.
Screening of a library of mutants obtained by random insertions of a transposon previously revealed that a member of the LDT family (YafK) is required for biofilm formation by an enteroaggregative strain of Escherichia coli (43). This prompted us to determine the impact of ldt deletions on biofilm formation by P. aeruginosa.
Our first objective was to evaluate the contribution of LDTs to peptidoglycan synthesis in biofilm (Table S2; Fig. 5). The proportion of 3→3 cross-linked dimers among all dimers was 11.3% in peptidoglycan extracted from biofilms, whereas 3→3 cross-links were not detected for exponential growth of PA14 in planktonic form (Fig. 5B). The relative proportion of dimers among all muropeptides was higher in biofilm than in planktonic cultures (44.2% versus 33.9%) (Fig. 5A). These results indicate that growth in biofilm favors peptidoglycan cross-linking by LdtPae1 and that this growth condition was associated with a highly cross-linked peptidoglycan. Growth in biofilm also favored the anchoring of OprI to peptidoglycan, indicating that LdtPae2 was active under this growth condition (Fig. 5C).
FIG 5.
Peptidoglycan structure of P. aeruginosa grown in biofilm and impact of ldt gene deletion on biofilm formation. (A) Proportion of dimers with 3→3 cross-links among all dimers (cumulative area of peaks 4 and 6 divided by the cumulative area of peaks 4 to 7 in rpHPLC chromatograms; λ = 205 nm). (B) Proportion of dimers among all muropeptides except peak 3 (cumulative area of peaks 4 to 7 divided by cumulative area of peak 1 to 7, except peak 3). (C) Proportion of muropeptides containing the Lys-Arg fragment of OprI among all muropeptides (cumulative area of peak 3 divided by cumulative area of peaks 1 to 7). Filled circles indicate the values obtained for biological repeats (n = 3). Horizontal lines indicate the mean percent values. * and **, P < 0.05 and P < 0.01, respectively; unpaired t test. BIOF, PA14 grown for 96 h in biofilm; EXPO, exponentially growing PA14 in planktonic form (OD600, 0.8). (D) Crystal violet staining of biofilms formed by wild-type P. aeruginosa PA14 and derivatives obtained by deletion of ldt genes and oprI. Circles indicate values obtained for biological repeats (n = 24). *, **, and ***, P < 0.05, P < 0.01, and P < 0.001, respectively (Brown-Forsythe and Welch ANOVA test).
Our second objective was to determine whether the activity of the LDTs modulate biofilm formation. The deletion of ldtPae1, ldtPae2, ldtPae3, or oprI resulted in statistically significant but limited decreases in the capacity of P. aeruginosa PA14 to form biofilm in the 96-well plate assay (Fig. 5D). The combine deletions of all three l,d-transpeptidases did not further decrease biofilm formation. Additionally, we also demonstrated that deletions of ldt genes or of oprI had no impact on the swimming motility of PA14, a biofilm-related function (Table S4), indicating that the cell envelope of the mutants was fully compatible with the assembly of a functional flagellum.
Comparison of LDTs catalyzing various reactions.
A peptidoglycan cross-linking activity was assigned to LdtPae1, a lipoprotein-anchoring activity was assigned to LdtPae2, and neither activity was assigned to LdtPae3 (see above) (Tables 1 and 2). The resulting extension in the number of functionally characterized LDTs prompted us to explore the phylogenetic relationships between members of this protein family (Table S5; Fig. S2 and S3). Closely related species were found to produce the same number of closely related LDTs, which share sequence identity over the entire sequences (e.g., E. coli and Salmonella enterica [6 paralogues], E. faecalis and E. faecium [1 paralogue], and Mycobacterium tuberculosis and Mycobacterium abscessus [6 paralogues]). More distantly related species, such as E. coli and P. aeruginosa or E. faecium and S. aureus (which does not harbor any LDT), produce various numbers of LDTs (0 to 6), and the domain composition is not conserved (Fig. S4).
We then evaluated whether LDTs catalyzing similar reactions could be identified based on the presence of specific sequence signatures. Winkle et al. identified a polymorphism in the conserved catalytic motif of E. coli LDTs (SXGChR versus SXGChA) and proposed that the latter motif was specific for enzymes hydrolyzing the amide bond connecting tripeptide stems to lipoproteins (YafK, also referred to as DpaA, in E. coli) (32, 33). LdtPae3 might be involved in the releasing of anchored OprI in P. aeruginosa, since this l,d-transpeptidase contains an SXGChA motif and is closely related to YafK (Table S5; Fig. S2 and S3). LdtPae2 (OprI anchoring) belonged to a lineage that included both E. coli Lpp anchoring (ErfK, YbiS, and YcfS) and peptidoglycan cross-linking (YnhG) enzymes. For LdtPae1 (formation of 3→3 cross-links), the highest levels of identity were observed for YciB from Bacillus subtilis (35.6%; unknown function), LdtMab3 from Mycobacterium abscessus (32.9%; unknown function), and YcfS of Campylobacter jejuni and E. coli (31.2% and 30.1%, unknown function and Lpp anchoring, respectively). Together, these results imply that LDTs with lipoprotein anchoring and 3→3 cross-linking activities cannot be assigned to two divergent evolutionary lineages, because they are scattered in the various branches of the phylogram depicted in Fig. S3.
LdtPae1 comprises two YkuD domains.
Sequence comparison indicated that LdtPae1, which catalyzes the formation of 3→3 peptidoglycan cross-links, comprises an N-terminal bona fide LDT catalytic domain with a conserved catalytic motif (SHGCIR), followed by a related domain that lacks the catalytic Cys residue (QLGKIR) (these domains are designated LdtPae1 and LdtPae11, respectively, in Table S5 and Fig. S2 and S3 and YkuD1 and YkuD2 in Fig. S4). These two domains are clustered in the same lineage, suggesting a duplication. This domain architecture has not been detected in any other LDT sequence. The role of the catalytically deficient domain LdtPae11 remains to be determined. It is tempting to speculate that it could be involved in peptidoglycan binding, a function mediated by unrelated domains in other LDTs (44, 45).
DISCUSSION
Active-site cysteine l,d-transpeptidases comprising a conserved YkuD domain catalyze various reactions (Fig. 1; see also the introduction) (46). Here, we show that P. aeruginosa may produce representatives of each of the three catalytic functions associated with the conserved YkuD catalytic domain, namely, the formation of 3→3 peptidoglycan cross-links (LdtPae1), the anchoring of lipoprotein OprI to peptidoglycan (LdtPae2), and the hydrolysis of the resulting tripeptide→OprI amide bond (LdtPae3). The activity of these enzymes was investigated by in vitro assays for purified LdtPae1 (Fig. 3), deletion of ldt genes from the chromosome of P. aeruginosa PA14 (Table 2), and heterologous expression of ldt genes in E. coli (Table 1). The functionality of LdtPae1 and LdtPae2 in the heterologous host might be accounted for by the conserved structures of both the peptidoglycan subunit of P. aeruginosa and E. coli (Fig. 2) and the Arg-Lys C terminus of lipoproteins OprI and Lpp (see Fig. S1 in the supplemental material). The function of LdtPae3 was tentatively assigned to the release of OprI based on both the absence of detectable amide bond-forming activity (formation of 3→3 and tripeptide→ OprI bonds) and the close similarity between LdtPae3 and E. coli hydrolase YafK.
Phylogenetic analysis revealed that the number of LDTs and their domain composition are not conserved except in closely related bacteria belonging to the same genus (Table S5 and Fig. S2 to S4). LDTs with lipoprotein anchoring and 3→3 cross-linking activities cannot be assigned to two distinct evolutionary lineages. Thus, although ldt genes appear to belong to bacterial core genomes, they are not stably inherited in distantly related lineages. In contrast, comparison of high-molecular-weight PBPs involved in peptidoglycan cross-linking clearly identifies orthologues in distantly related lineages (47).
The phenotypic impact of deletions of ldt genes and of oprI has been explored using various assays. The deletion of these genes did not result in hypersusceptibility to antibiotics or impaired motility (Tables S3 and S4, respectively). These observations indicate that the permeability barrier of the outer membrane and the functionality of the flagellum were preserved in the mutants. Loss of OprI or of the anchoring of this lipoprotein to peptidoglycan led to a destabilization of the cell envelope, as revealed by the bactericidal effect of EDTA (Fig. 4). In contrast, formation of 3→3 cross-links by LdtPae1 was dispensable for survival in the presence of EDTA. Similar results were previously obtained for mutants of E. coli deficient in the production of Lpp or in the anchoring of this lipoprotein to peptidoglycan (30).
Formation of 3→3 cross-links remained undetected for exponential growth of P. aeruginosa PA14 in planktonic form (Fig. 5B). The proportion of 3→3 cross-links was significantly higher (11.3%) for growth in biofilm (P < 0.01). Deletion of ldtPae1 had a modest but significant (P < 0.05) impact on the ability of P. aeruginosa PA14 to form biofilms (Fig. 5D). These results indicate that 3→3 cross-linking of glycan strands participates in the adaptation of peptidoglycan metabolism to conditions that prevail in biofilm. Interestingly, muropeptides containing 3→3 cross-links were found to be more abundant in P. aeruginosa epidemic strains than in reference strains PAO1 and PA14 (40). In addition, deletion of ldtPae2 or oprI impaired biofilm formation and sensitized mutants to EDTA. Thus, l,d-transpeptidases might be actionable targets to fight against bacteria in biofilm. Considering the impact of ldt gene deletions on the bactericidal activity of EDTA (Fig. 4), it would be relevant to determine whether inhibition of LDTs of Gram-negative bacteria could act in synergy with drug-EDTA associations for the eradication of catheter-associated biofilms based on antibiotic lock therapy or in treatment of other biofilm-related infections (48–50).
MATERIALS AND METHODS
Bacterial strains and plasmids.
The characteristics and origin of plasmids and bacterial strains are given in Tables S6 and S7, respectively, in the supplemental material.
Cultures for peptidoglycan extraction.
For the analyses of the muropeptide composition of the peptidoglycan from P. aeruginosa PA14 and derivatives obtained by deletion of ldt genes and oprI, bacteria were grown overnight to stationary phase in 200 mL lysogeny (Miller) broth (LB) at 37°C. For quantitative analyses of the peptidoglycan of P. aeruginosa PA14 in the exponential phase of growth, bacteria were grown in 1 L of LB broth and collected at an optical density at 600 nm (OD600) of 0.8. For quantitative analyses of the peptidoglycan of P. aeruginosa PA14 grown in biofilm, continuous-flow biofilm microfermentors containing a removable glass spatula were used as described previously (51). Biofilm microfermentors were inoculated by placing the spatula in a culture solution adjusted to an OD600 of 1.0 (ca. 5.0 × 108 bacteria/mL) for 5 min. The spatula was placed into the microfermentor, and biofilm culture was performed at 37°C in Miller LB broth. The flow rate was adjusted so that the total time for renewal of microfermentor medium was shorter than the bacterial generation time, thus minimizing planktonic growth by constant dilution of nonbiofilm bacteria. Biofilms were allowed to grow on the glass spatula for 72 h, after which the microfermentor was vortexed for 1 min to resuspend the bacterial population. The resulting bacterial suspension (50 mL) was centrifuged for 15 min at 7,000 × g (4°C), and peptidoglycan was extracted by the hot SDS procedure. Peptidoglycan analyses were performed for a minimum of three biological repeats.
Analysis of peptidoglycan structure.
Sacculi were extracted by the hot SDS procedure and treated with pronase and trypsin (7, 52). Muropeptides were solubilized by digestion with muramidases, reduced with NaBH4, and purified by rpHPLC. The mass of muropeptides was determined on a Bruker Daltonics maXis high-resolution MS (Bremen Germany) operating in the positive mode, as previously described (53, 54).
Heterospecific expression of P. aeruginosa ldt genes in E. coli BW25113 Δ6ldt.
Genes ldtPae1, ldtPae2, and ldtPae3 were cloned into the vector pHV6 under the control of the trc promoter by Gibson assembly. Genes encoding LDTs were induced at an OD600 of 0.2 with 100 μM IPTG in LB broth. The incubation was continued for 18 h at 37°C.
Purification of LdtPae1.
A fragment of the ldtPae1 gene encoding residues 33 to 347 of the l,d-transpeptidase was cloned into the vector pET-TEV, generating a translational fusion with a C-terminal 6×His tag. The protein was produced in E. coli BL21 and purified from a clarified lysate by metal affinity and size exclusion chromatography as previously performed for l,d-transpeptidase YcbB from E. coli (7). The protein concentration was determined by the Bio-Rad assay, using bovine serum albumin as the standard.
Peptidoglycan transpeptidase activity of purified LdtPae1.
Reduced disaccharide-tetrapeptide and lactoyl-tetrapeptide were extracted from the peptidoglycan of E. coli BW25113 Δ6ldt as previously described (55). Purified LdtPae1 (5 μM) was incubated with peptidoglycan fragments (50 μM) in 25 mM Tris-HCl (pH 8.0) at 20°C. LC-MS was performed with a Nucleoshell RP 18 column (5 μm; 50 mm by 2 mm) coupled to a low-resolution LCQ Advantage mass spectrometer (ThermoElectron). The reactions were also carried out in the presence of additional d-Met (1 mM).
MS analyses of LdtPae1 acylation by β-lactams.
The formation of drug-enzyme adducts was tested by incubating LdtPae1 (10 μM) with β-lactams (100 μM) at 20°C in 5 mM Tris-HCl (pH 8.0) (9). Five microliters of acetonitrile and 1 μL of 1% formic acid were added, and the reaction mixture was directly injected into the MS. Spectra were acquired in the positive mode on a Bruker Daltonics maXis high-resolution MS (Bremen, Germany) operating in the positive mode.
Deletion of genes ldtPae1, ldtPae2, ldtPae3, and oprI of P. aeruginosa PA14.
The two-step allelic exchange procedure was used for deleting ldt genes and oprI (56). Briefly, sequences flanking the genes were cloned into the vector pEX18. The plasmids were transferred by conjugation from E. coli S17 λpir to P. aeruginosa PA14. Transconjugants were selected on LB agar plates containing 15 μg/mL triclosan and 75 μg/mL tetracycline. Colonies were subcultured in salt-free LB containing 5% sucrose. The genome of the mutants was sequenced by the Illumina approach (Novogene, Cambridge, UK).
Antimicrobial susceptibility testing.
Antibiograms were performed in triplicate by the disk diffusion assay in cation-adjusted Mueller-Hinton agar plates according to the guidelines of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (57).
Bactericidal activity of EDTA.
Bacteria were grown overnight to the stationary phase in LB (Miller) broth at 37°C, washed twice in 50 mM Tris-HCl buffer (pH 8.0), and resuspended in the same buffer to a final OD600 of 0.9. EDTA was added (final concentration, 500 μM), bacteria were incubated in 2-mL Eppendorf tubes at 37°C, and samples were withdrawn at 90 min, 180 min, and 270 min for viable cell counts on agar plates. Data were obtained in three biological repeats.
Plate-based assay for swimming motility.
An isolated colony from an overnight agar plate was inoculated onto a soft agar plate containing tryptone broth (10 g/L), NaCl (5 g/L), and agar (0.3%, wt/vol) (58). The plates were incubated for 18 h at 30°C, and the swimming diameter was recorded. Data were obtained in three biological repeats.
Quantification of biofilm.
Formation of biofilm was determined by crystal violet staining in 96-well microtiter plates, as previously described (59). A microtiter plate was inoculated with 100 μL of overnight cultures at a dilution of 1:100 and incubated at 37°C for 24 h. The medium was removed, and the wells were washed twice with water. A 125-μL volume of a crystal violet solution (RAL Diagnostics) was added to each well, and the incubation was continued for 15 min. After washing three times with water, 125 μL of a mixture of ethanol and acetone (80/20, vol/vol) was added, and incubation was continued for 10 min. Absorbance was measured at 570 nm with a plate reader (Tecan Infinite 200Pro). Data were obtained in 24 biological repeats.
Statistical analysis.
The data were analyzed using GraphPad Prism version 9 (La Jolla, CA, USA). An unpaired t test was performed to analyze the relative abundance of dimers and 3→3 cross-links in the peptidoglycan of P. aeruginosa PA14. A Brown-Forsythe and Welch analysis of variance (ANOVA) test was performed to analyze the impact of ldt gene deletions on bacterial killing by EDTA and the quantification of biofilm formation. A P value of 0.05 was considered statistically significant in both types of tests.
Sequence comparison and phylogeny.
Forty YkuD-related domains were retrieved from the genome of 12 bacterial species, including E. coli (E. coli_YcfS, E. coli_YcbB, E. coli_YnhG, E. coli_Ybis, E. coli_ErfK, and E. coli_YafK), P. aeruginosa (LdtPae1 and its second YkuD domain named LdtPae11, LdtPae2, and LdtPae3), Salmonella enterica serovar Typhimurium (Sty_YcfS, Sty_YcbB, Sty_YnhG, Sty_Ybis, Sty_ErfK, and Sty_YafK), Campylobacter jejuni (Cje_YcfS and Cje_Ybis), Neisseria meningitidis (LdtNme), Bacillus subtilis (Bs_YkuD, Bs_YqjB, and Bs_YciB), Clostridioides difficile (LdtCd1, LdtCd2, and LdtCd3), Mycobacterium tuberculosis (LdtMt1 to LdtMt6), Mycobacterium abscessus (LdtMab1 to LdtMab6), Enterococcus faecium (Ldtfm), Enterococcus faecalis (Ldtfs), and Coxiella burnettii (LdtCbu2). The sequences of the domains were aligned using Clustal Omega (Fig. S2), providing the identity matrix reported in Table S5. The phylogram reported in Fig. S3 was obtained on iTOL (60).
Supplementary Material
ACKNOWLEDGMENTS
High-resolution mass spectra were obtained at the Plateforme de Spectrométrie de Masse Bio-organique of the Muséum d’Histoire Naturel. We thank A. Filloux for the generous gift of P. aeruginosa mutants obtained by transposon insertion (full library available at http://pa14.mgh.harvard.edu/cgi-bin/pa14/mutantrequest.cgi).
This work was supported by the French National Research Agency (ANR) (grant no. ANR-19-CE15-0006-01, PeptidoAdapt, Program AAPG 2019 to M.A. and J.-M.G.). This work was also supported by the French government's Investissement d'Avenir Program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (grant no. ANR-10-LABX-62-IBEID). S.T.-R was supported by the ANR, project EvolTolAB (grant no. ANR-18-CE13-0010).
Footnotes
[This article was published on 31 May 2023 with Christophe Beloin's name missing from the corresponding author footnote. The footnote was updated in the current version, posted on 5 June 2023.]
Supplemental material is available online only.
Contributor Information
Christophe Beloin, Email: christophe.beloin@pasteur.fr.
Michel Arthur, Email: michel.arthur@crc.jussieu.fr.
Eric Cascales, Centre National de la Recherche Scientifique, Aix-Marseille Université.
Erin Gloag, Virginia Polytechnic Institute and State University.
REFERENCES
- 1.Vollmer W, Blanot D, De Pedro MA. 2008. Peptidoglycan structure and architecture. FEMS Microbiol Rev 32:149–167. doi: 10.1111/j.1574-6976.2007.00094.x. [DOI] [PubMed] [Google Scholar]
- 2.Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. 2008. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev 32:234–258. doi: 10.1111/j.1574-6976.2008.00105.x. [DOI] [PubMed] [Google Scholar]
- 3.Mainardi J-L, Fourgeaud M, Hugonnet J-E, Dubost L, Brouard J-P, Ouazzani J, Rice LB, Gutmann L, Arthur M. 2005. A novel peptidoglycan cross-linking enzyme for a β-lactam-resistant transpeptidation pathway. J Biol Chem 280:38146–38152. doi: 10.1074/jbc.M507384200. [DOI] [PubMed] [Google Scholar]
- 4.Mainardi J-L, Legrand R, Arthur M, Schoot B, van Heijenoort J, Gutmann L. 2000. Novel mechanism of β-lactam resistance due to bypass of dd-transpeptidation in Enterococcus faecium. J Biol Chem 275:16490–16496. doi: 10.1074/jbc.M909877199. [DOI] [PubMed] [Google Scholar]
- 5.Mainardi J-L, Morel V, Fourgeaud M, Cremniter J, Blanot D, Legrand R, Fréhel C, Arthur M, van Heijenoort J, Gutmann L. 2002. Balance between two transpeptidation mechanisms determines the expression of β-lactam resistance in Enterococcus faecium. J Biol Chem 277:35801–35807. doi: 10.1074/jbc.M204319200. [DOI] [PubMed] [Google Scholar]
- 6.Sacco E, Hugonnet J-E, Josseaume N, Cremniter J, Dubost L, Marie A, Patin D, Blanot D, Rice LB, Mainardi J-L, Arthur M. 2010. Activation of the l,d-transpeptidation peptidoglycan cross-linking pathway by a metallo-d,d-carboxypeptidase in Enterococcus faecium. Mol Microbiol 75:874–885. doi: 10.1111/j.1365-2958.2009.07014.x. [DOI] [PubMed] [Google Scholar]
- 7.Hugonnet J-E, Mengin-Lecreulx D, Monton A, den Blaauwen T, Carbonnelle E, Veckerlé C, Brun YV, van Nieuwenhze M, Bouchier C, Tu K, Rice LB, Arthur M. 2016. Factors essential for l,d-transpeptidase-mediated peptidoglycan cross-linking and β-lactam resistance in Escherichia coli. Elife 5:e19469. doi: 10.7554/eLife.19469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Biarrotte-Sorin S, Hugonnet J-E, Delfosse V, Mainardi J-L, Gutmann L, Arthur M, Mayer C. 2006. Crystal structure of a novel β-lactam-insensitive peptidoglycan transpeptidase. J Mol Biol 359:533–538. doi: 10.1016/j.jmb.2006.03.014. [DOI] [PubMed] [Google Scholar]
- 9.Mainardi J-L, Hugonnet J-E, Rusconi F, Fourgeaud M, Dubost L, Moumi AN, Delfosse V, Mayer C, Gutmann L, Rice LB, Arthur M. 2007. Unexpected inhibition of peptidoglycan ld-transpeptidase from Enterococcus faecium by the β-lactam imipenem. J Biol Chem 282:30414–30422. doi: 10.1074/jbc.M704286200. [DOI] [PubMed] [Google Scholar]
- 10.Dubée V, Arthur M, Fief H, Triboulet S, Mainardi J-L, Gutmann L, Sollogoub M, Rice LB, Ethève-Quelquejeu M, Hugonnet J-E. 2012. Kinetic analysis of Enterococcus faecium l,d-transpeptidase inactivation by carbapenems. Antimicrob Agents Chemother 56:3409–3412. doi: 10.1128/AAC.06398-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Dubée V, Triboulet S, Mainardi J-L, Ethève-Quelquejeu M, Gutmann L, Marie A, Dubost L, Hugonnet J-E, Arthur M. 2012. Inactivation of Mycobacterium tuberculosis l,d-transpeptidase LdtMt1 by carbapenems and cephalosporins. Antimicrob Agents Chemother 56:4189–4195. doi: 10.1128/AAC.00665-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Triboulet S, Dubée V, Lecoq L, Bougault C, Mainardi J-L, Rice LB, Ethève-Quelquejeu M, Gutmann L, Marie A, Dubost L, Hugonnet J-E, Simorre J-P, Arthur M. 2013. Kinetic features of l,d-transpeptidase inactivation critical for β-lactam antibacterial activity. PLoS One 8:e67831. doi: 10.1371/journal.pone.0067831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cordillot M, Dubée V, Triboulet S, Dubost L, Marie A, Hugonnet J-E, Arthur M, Mainardi J-L. 2013. In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by l,d-transpeptidases and inactivation of these enzymes by carbapenems. Antimicrob Agents Chemother 57:5940–5945. doi: 10.1128/AAC.01663-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Peltier J, Courtin P, El Meouche I, Lemée L, Chapot-Chartier M-P, Pons J-L. 2011. Clostridium difficile has an original peptidoglycan structure with a high level of N-acetylglucosamine deacetylation and mainly 3–3 cross-links. J Biol Chem 286:29053–29062. doi: 10.1074/jbc.M111.259150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sütterlin L, Edoo Z, Hugonnet J-E, Mainardi J-L, Arthur M. 2018. Peptidoglycan cross-linking activity of l,d-transpeptidases from Clostridium difficile and inactivation of these enzymes by β-lactams. Antimicrob Agents Chemother 62:e01607-17. doi: 10.1128/AAC.01607-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hernández SB, Dörr T, Waldor MK, Cava F. 2020. Modulation of peptidoglycan synthesis by recycled cell wall tetrapeptides. Cell Rep 31:107578. doi: 10.1016/j.celrep.2020.107578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tolufashe GF, Sabe VT, Ibeji CU, Ntombela T, Govender T, Maguire GEM, Kruger HG, Lamichhane G, Honarparvar B. 2020. Structure and function of l,d- and d,d-transpeptidase family enzymes from Mycobacterium tuberculosis. Curr Med Chem 27:3250–3267. doi: 10.2174/0929867326666181203150231. [DOI] [PubMed] [Google Scholar]
- 18.Aliashkevich A, Cava F. 2022. ld-transpeptidases: the great unknown among the peptidoglycan cross-linkers. FEBS J 289:4718–4730. doi: 10.1111/febs.16066. [DOI] [PubMed] [Google Scholar]
- 19.Baranowski C, Welsh MA, Sham L-T, Eskandarian HA, Lim HC, Kieser KJ, Wagner JC, McKinney JD, Fantner GE, Ioerger TR, Walker S, Bernhardt TG, Rubin EJ, Rego EH. 2018. Maturing Mycobacterium smegmatis peptidoglycan requires non-canonical crosslinks to maintain shape. Elife 7:e37516. doi: 10.7554/eLife.37516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.García-Heredia A, Pohane AA, Melzer ES, Carr CR, Fiolek TJ, Rundell SR, Lim HC, Wagner JC, Morita YS, Swarts BM, Siegrist MS. 2018. Peptidoglycan precursor synthesis along the sidewall of pole-growing mycobacteria. Elife 7:e37243. doi: 10.7554/eLife.37243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lavollay M, Fourgeaud M, Herrmann J-L, Dubost L, Marie A, Gutmann L, Arthur M, Mainardi J-L. 2011. The peptidoglycan of Mycobacterium abscessus is predominantly cross-linked by l,d-transpeptidases. J Bacteriol 193:778–782. doi: 10.1128/JB.00606-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lavollay M, Arthur M, Fourgeaud M, Dubost L, Marie A, Veziris N, Blanot D, Gutmann L, Mainardi J-L. 2008. The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by l,d-transpeptidation. J Bacteriol 190:4360–4366. doi: 10.1128/JB.00239-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Glauner B, Höltje JV, Schwarz U. 1988. The composition of the murein of Escherichia coli. J Biol Chem 263:10088–10095. doi: 10.1016/S0021-9258(19)81481-3. [DOI] [PubMed] [Google Scholar]
- 24.Gupta R, Lavollay M, Mainardi J-L, Arthur M, Bishai WR, Lamichhane G. 2010. The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin. Nat Med 16:466–469. doi: 10.1038/nm.2120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Pisabarro AG, de Pedro MA, Vázquez D. 1985. Structural modifications in the peptidoglycan of Escherichia coli associated with changes in the state of growth of the culture. J Bacteriol 161:238–242. doi: 10.1128/jb.161.1.238-242.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Morè N, Martorana AM, Biboy J, Otten C, Winkle M, Serrano CKG, Montón Silva A, Atkinson L, Yau H, Breukink E, den Blaauwen T, Vollmer W, Polissi A. 2019. Peptidoglycan remodeling enables Escherichia coli to survive severe outer membrane assembly defect. mBio 10:e02729-18. doi: 10.1128/mBio.02729-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Geiger T, Pazos M, Lara-Tejero M, Vollmer W, Galán JE. 2018. Peptidoglycan editing by a specific ld-transpeptidase controls the muramidase-dependent secretion of typhoid toxin. Nat Microbiol 3:1243–1254. doi: 10.1038/s41564-018-0248-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Braun V, Wolff H. 1970. The murein-lipoprotein linkage in the cell wall of Escherichia coli. Eur J Biochem 14:387–391. doi: 10.1111/j.1432-1033.1970.tb00301.x. [DOI] [PubMed] [Google Scholar]
- 29.Magnet S, Bellais S, Dubost L, Fourgeaud M, Mainardi J-L, Petit-Frère S, Marie A, Mengin-Lecreulx D, Arthur M, Gutmann L. 2007. Identification of the l,d-transpeptidases responsible for attachment of the Braun lipoprotein to Escherichia coli peptidoglycan. J Bacteriol 189:3927–3931. doi: 10.1128/JB.00084-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Sanders AN, Pavelka MS. 2013. Phenotypic analysis of Escherichia coli mutants lacking l,d-transpeptidases. Microbiology (Reading) 159:1842–1852. doi: 10.1099/mic.0.069211-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sandoz KM, Moore RA, Beare PA, Patel AV, Smith RE, Bern M, Hwang H, Cooper CJ, Priola SA, Parks JM, Gumbart JC, Mesnage S, Heinzen RA. 2021. β-Barrel proteins tether the outer membrane in many Gram-negative bacteria. Nat Microbiol 6:19–26. doi: 10.1038/s41564-020-00798-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Bahadur R, Chodisetti PK, Reddy M. 2021. Cleavage of Braun’s lipoprotein Lpp from the bacterial peptidoglycan by a paralog of l,d-transpeptidases, LdtF. Proc Natl Acad Sci USA 118:e2101989118. doi: 10.1073/pnas.2101989118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Winkle M, Hernández-Rocamora VM, Pullela K, Goodall ECA, Martorana AM, Gray J, Henderson IR, Polissi A, Vollmer W. 2021. DpaA detaches Braun’s lipoprotein from peptidoglycan. mBio 12:e00836-21. doi: 10.1128/mBio.00836-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Cava F, de Pedro MA, Lam H, Davis BM, Waldor MK. 2011. Distinct pathways for modification of the bacterial cell wall by non-canonical d-amino acids: distinct pathways for cell wall remodelling. EMBO J 30:3442–3453. doi: 10.1038/emboj.2011.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Dai Y, Pinedo V, Tang AY, Cava F, Geisinger E. 2021. A new class of cell wall-recycling l,d-carboxypeptidase determines b-lactam susceptibility and morphogenesis in Acinetobacter baumannii. mBio 12:19. doi: 10.1128/mBio.02786-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lam J, Chan R, Lam K, Costerton JW. 1980. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 28:546–556. doi: 10.1128/iai.28.2.546-556.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lebeaux D, Ghigo J-M, Beloin C. 2014. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 78:510–543. doi: 10.1128/MMBR.00013-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Reynolds D, Kollef M. 2021. The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs 81:2117–2131. doi: 10.1007/s40265-021-01635-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Anderson EM, Sychantha D, Brewer D, Clarke AJ, Geddes-McAlister J, Khursigara CM. 2020. Peptidoglycomics reveals compositional changes in peptidoglycan between biofilm- and planktonic-derived Pseudomonas aeruginosa. J Biol Chem 295:504–516. doi: 10.1074/jbc.RA119.010505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Anderson EM, Shaji Saji N, Anderson AC, Brewer D, Clarke AJ, Khursigara CM. 2022. Pseudomonas aeruginosa alters peptidoglycan composition under nutrient conditions resembling cystic fibrosis lung infections. mSystems 7:e00156-22. doi: 10.1128/msystems.00156-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kumar P, Chauhan V, Silva JRA, Lameira J, d'Andrea FB, Li S-G, Ginell SL, Freundlich JS, Alves CN, Bailey S, Cohen KA, Lamichhane G. 2017. Mycobacterium abscessus l,d-transpeptidases are susceptible to inactivation by carbapenems and cephalosporins but not penicillins. Antimicrob Agents Chemother 61:e00866-17. doi: 10.1128/AAC.00866-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Voedts H, Kennedy SP, Sezonov G, Arthur M, Hugonnet J-E. 2022. Genome-wide identification of genes required for alternative peptidoglycan cross-linking in Escherichia coli revealed an unexpected impact of β-lactams. Nat Commun 13:7962. doi: 10.1038/s41467-022-35528-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sheikh J, Hicks S, Dall'Agnol M, Phillips AD, Nataro JP. 2001. Roles for Fis and YafK in biofilm formation by enteroaggregative Escherichia coli: biofilm formation by EAEC. Mol Microbiol 41:983–997. doi: 10.1046/j.1365-2958.2001.02512.x. [DOI] [PubMed] [Google Scholar]
- 44.Lecoq L, Bougault C, Hugonnet J-E, Veckerlé C, Pessey O, Arthur M, Simorre J-P. 2012. Dynamics induced by β-lactam antibiotics in the active site of Bacillus subtilis l,d-transpeptidase. Structure 20:850–861. doi: 10.1016/j.str.2012.03.015. [DOI] [PubMed] [Google Scholar]
- 45.Caveney NA, Caballero G, Voedts H, Niciforovic A, Worrall LJ, Vuckovic M, Fonvielle M, Hugonnet J-E, Arthur M, Strynadka NCJ. 2019. Structural insight into YcbB-mediated beta-lactam resistance in Escherichia coli. Nat Commun 10:1849. doi: 10.1038/s41467-019-09507-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Zandi TA, Marshburn RL, Stateler PK, Brammer Basta LA. 2019. Phylogenetic and biochemical analyses of mycobacterial l,d-transpeptidases reveal a distinct enzyme class that is preferentially acylated by meropenem. ACS Infect Dis 5:2047–2054. doi: 10.1021/acsinfecdis.9b00234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Goffin C, Ghuysen J-M. 1998. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol Mol Biol Rev 62:1079–1093. doi: 10.1128/MMBR.62.4.1079-1093.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Chauhan A, Lebeaux D, Ghigo J-M, Beloin C. 2012. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother 56:6310–6318. doi: 10.1128/AAC.01606-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Finnegan S, Percival SL. 2015. EDTA: an antimicrobial and antibiofilm agent for use in wound care. Adv Wound Care (New Rochelle) 4:415–421. doi: 10.1089/wound.2014.0577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Lebeaux D, Leflon-Guibout V, Ghigo J-M, Beloin C. 2015. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections. J Antimicrob Chemother 70:1704–1712. doi: 10.1093/jac/dkv044. [DOI] [PubMed] [Google Scholar]
- 51.Ghigo J-M. 2001. Natural conjugative plasmids induce bacterial biofilm development. Nature 412:442–445. doi: 10.1038/35086581. [DOI] [PubMed] [Google Scholar]
- 52.Magnet S, Dubost L, Marie A, Arthur M, Gutmann L. 2008. Identification of the l,d-transpeptidases for peptidoglycan cross-linking in Escherichia coli. J Bacteriol 190:4782–4785. doi: 10.1128/JB.00025-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Voedts H, Dorchêne D, Lodge A, Vollmer W, Arthur M, Hugonnet J. 2021. Role of endopeptidases in peptidoglycan synthesis mediated by alternative cross-linking enzymes in Escherichia coli. EMBO J 40:e108126. doi: 10.15252/embj.2021108126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Atze H, Liang Y, Hugonnet J-E, Gutierrez A, Rusconi F, Arthur M. 2022. Heavy isotope labeling and mass spectrometry reveal unexpected remodeling of bacterial cell wall expansion in response to drugs. Elife 11:e72863. doi: 10.7554/eLife.72863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Bouhss A, Josseaume N, Severin A, Tabei K, Hugonnet J-E, Shlaes D, Mengin-Lecreulx D, van Heijenoort J, Arthur M. 2002. Synthesis of the l-alanyl-l-alanine cross-bridge of Enterococcus faecalis peptidoglycan. J Biol Chem 277:45935–45941. doi: 10.1074/jbc.M207449200. [DOI] [PubMed] [Google Scholar]
- 56.Hmelo LR, Borlee BR, Almblad H, Love ME, Randall TE, Tseng BS, Lin C, Irie Y, Storek KM, Yang JJ, Siehnel RJ, Howell PL, Singh PK, Tolker-Nielsen T, Parsek MR, Schweizer HP, Harrison JJ. 2015. Precision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchange. Nat Protoc 10:1820–1841. doi: 10.1038/nprot.2015.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.European Committee on Antimicrobial Susceptibility Testing. 2022. Antimicrobial susceptibility testing EUCAST disk diffusion method. EUCAST, Växjö, Sweden. [Google Scholar]
- 58.Rashid MH, Kornberg A. 2000. Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 97:4885–4890. doi: 10.1073/pnas.060030097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.O'Toole GA. 2011. Microtiter dish biofilm formation assay. J Vis Exp 47:2437. doi: 10.3791/2437-v. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Letunic I, Bork P. 2021. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 49:W293–W296. doi: 10.1093/nar/gkab301. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental material. Download spectrum.05217-22-s0001.pdf, PDF file, 1.2 MB (1.2MB, pdf)





